4/2
03:04 pm
mnpr
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Robinson Chandler
Low
Report
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Robinson Chandler
4/2
03:03 pm
mnpr
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Cittadine Andrew
Low
Report
Form 4 Monopar Therapeutics For: Mar 31 Filed by: Cittadine Andrew
4/1
12:24 pm
mnpr
Form 10-K/A Monopar Therapeutics For: Dec 31
Medium
Report
Form 10-K/A Monopar Therapeutics For: Dec 31
3/27
01:27 pm
mnpr
Form 8-K Monopar Therapeutics For: Mar 27
Medium
Report
Form 8-K Monopar Therapeutics For: Mar 27
3/27
01:01 pm
mnpr
Form 10-K Monopar Therapeutics For: Dec 31
Low
Report
Form 10-K Monopar Therapeutics For: Dec 31
3/4
05:26 pm
mnpr
Form 4 Monopar Therapeutics For: Mar 02 Filed by: Rodriguez Susan
Low
Report
Form 4 Monopar Therapeutics For: Mar 02 Filed by: Rodriguez Susan
3/4
05:25 pm
mnpr
Form 3 Monopar Therapeutics For: Mar 02 Filed by: Rodriguez Susan
Low
Report
Form 3 Monopar Therapeutics For: Mar 02 Filed by: Rodriguez Susan
3/2
08:01 am
mnpr
Form 8-K Monopar Therapeutics For: Mar 02
Medium
Report
Form 8-K Monopar Therapeutics For: Mar 02
2/17
04:39 pm
mnpr
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
2/6
09:55 am
mnpr
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: ASTRAZENECA PLC
Low
Report
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: ASTRAZENECA PLC
1/30
02:32 pm
mnpr
Form SCHEDULE 13D/A Monopar Therapeutics Filed by: Tactic Pharma LLC
Low
Report
Form SCHEDULE 13D/A Monopar Therapeutics Filed by: Tactic Pharma LLC
1/30
02:31 pm
mnpr
Form 4 Monopar Therapeutics For: Jan 28 Filed by: Robinson Chandler
Low
Report
Form 4 Monopar Therapeutics For: Jan 28 Filed by: Robinson Chandler